Last updated 12 days ago

A Study of Brenipatide in Adult Participants With Schizophrenia

450 patients around the world

Available in Argentina, United States, Brazil

Eli Lilly and Company

20Research sites

450Patients around the world

This study is for people with

Schizophrenia

To 55 Years

All Gender

: Meet the diagnostic criteria of schizophrenia.
Are on a stable standard of care medication regimen for schizophrenia.
If the duration of illness is greater than 6 years, participant has experienced at least one relapse of schizophrenia in last 3 years.
Have at least 1 reliable study partner (for example, a family member, social worker, caseworker, residential facility staff, or nurse).
Are reliable and willing to make themselves available for the duration of the study and attend required study visits, and are willing and able to follow study procedures as required.
Self-inject study intervention store and use the provided study intervention as directed.
Maintain electronic or paper study diaries, as applicable.
Complete the required questionnaires.

: Have lifetime history of bipolar disorder, borderline personality disorder, or any eating disorder.
Evidence of moderate or severe substance or alcohol use disorder within 180 days of screening.
Have type 1 diabetes, or history of ketoacidosis or hyperosmolar state or coma.
Are actively suicidal or deemed to be a significant risk for suicide.
Are currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study.

CENYDET Centro Neurobiológico y de Estrés Traumático (Biopsychomedical Research Group S.R.L.)

Marcelo T de Alvear 768 - 4° "A" CABA - Ciudad Autónoma de Bs As 1058AAJ

Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires

Viamonte 2213, C1056ABI Cdad. Autónoma de Buenos Aires, Argentina

Instituto Médico de la Fundación Estudios Clínicos - Rosario

Italia 428, Rosario - Santa Fe

Instituto Privado Kremer

Coronel Pringles 73, Córdoba

Centro Médico Luquez

Sargento Cabral 1385, Córdoba

Instituto de Neurociencias San Agustín - INSA

Calle 57 Nro. 1647 esq 28 La Plata 1900 - Buenos Aires

Centro de Investigación y Asistencia en Psiquiatría - CIAP

Martín Rodriguez 1215, Rosario, Santa Fe

CEN Centro Especializado en Neurociencias

Barrio General Paz D. Faustino Sarmiento 1564 - Córdoba 5004

Sanatorio Privado Prof. Leon S Morra S.A.

Av. Sagrada Familia esq. Nazaret X5009 - Córdoba

Fundación para el Estudio y Tratamiento de las Enfermedades Mentales (FETEM)

Av Entre Ríos 1981 CABA C1133AAH - CABA

StudyRENEW-Scz-1

SponsorEli Lilly and Company

Study typeInterventional

Conditions

Schizophrenia

Requirements

To 55 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT07410507